Ludi A B, Morris A, Gubbins S, Asfor A, Afzal M, Browning C F, Grazioli S, Foglia E A, Wilsden G, Burman A, Brocchi E, Paton D J, King D P (2022)
Cross-Serotype reactivity of ELISAs used to detect antibodies to the structural proteins of foot-and-mouth disease virus
Viruses 14 (7) , 1495
Publisher’s version: https://www.doi.org/10.3390/v14071495
Yang M, Zhmendak D, Mioulet V, King D P, Burman A, Nfon C K (2022)
Combining a universal capture ligand and pan-serotype monoclonal antibody to develop a pan-serotype lateral flow strip test for foot-and-mouth disease virus detection
Viruses 14 (4) , 785
Publisher’s version: https://doi.org/10.3390/v14040785
Li H, Dekker A, Sun S, Burman A, Kortekaas J, Harmsen M M (2021)
Novel capsid-specific single-domain antibodies with broad foot-and-mouth disease strain recognition reveal differences in antigenicity of virions, empty capsids and virus-like particles
Vaccines 9 (6) , 620
Publisher’s version: https://doi.org/10.3390/vaccines9060620
Swanson J, Fragkoudis R, Hawes P C, Newman J, Burman A, Panjwani A, Stonehouse N J, Tuthill T J (2021)
Generation of Antibodies against Foot-and-Mouth-Disease Virus Capsid Protein VP4 Using Hepatitis B Core VLPs as a Scaffold
Life 11 (4) , 338
Publisher’s version: https://doi.org/10.3390/life11040338
Tan T K, Rijal P, Rahikainen R, Keeble A H, Schimanski L, Hussain S, Harvey R, Hayes J W P, Edwards J C, McLean R K, Martini V, Pedrera M, Thakur N, Conceicao C, Dietrich I, Shelton H, Ludi A, Wilsden G, Browning C, Zagrajek A K, Bialy D, Bhat S, Stevenson-Leggett P, Hollinghurst P, Tully M, Moffat K, Chiu C, Waters R, Gray A, Azhar M, Mioulet V, Newman J, Asfor A S, Burman A, Crossley S, Hammond J A, Tchilian E, Charleston B, Bailey D, Tuthill T J, Graham S P, Duyvesteyn H M E, Malinauskas T, Huo J, Tree J A, Buttigieg K R, Owens R J, Carroll M W, Daniels R S, McCauley J W, Stuart D I, Huang K A, Howarth M, Townsend A R (2021)
A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses
Nature Communications 12 , 542
Publisher’s version: https://doi.org/10.1038/s41467-020-20654-7